Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases
Using the current cutoff values, the non-invasive assessments demonstrated almost perfect consistency in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with liver diseases, though FIB-4 and GPR showed moderate consistency in cirrhosis evaluation in patients with coexisting liver conditions. Moreover, it also indicated that increased liver fibrosis correlates with more severe COVID-19 and prolonged coronavirus negative conversion time.
Authors
- Chen Zhu (ORCID: https://orcid.org/0000-0002-1002-8387)
- Lijuan Lan
- Dafeng Liu (ORCID: https://orcid.org/0000-0002-6792-641X)
- Xiaoping Yu (ORCID: https://orcid.org/0000-0003-4502-1027)
- Jun Kang (ORCID: https://orcid.org/0000-0002-6934-4341)
- Yan Pan (ORCID: https://orcid.org/0000-0001-6191-1009)
- Bennan Zhao
Institutions
- Chengdu Medical College (CN)
- Chengdu University (CN)
- Public Health Clinical Center of Chengdu (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1186/s12876-025-03770-w
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Chengdu Science and Technology Bureau